APOL
Apollon Formularies plc
Access
ISIN
IM00BJ0LRD77
Bid
0.12
Mid
0.16
Ask
0.20
Key Information
- Price Change
- 0.00%
- Year High
- 1.65
- Year Low
- 0.16
- Last Trade
- 2 Jun 23
- Market Cap
- £1.23M
- Par
- 0.00
- Bid
- 0.12
- Mid Price
- 0.16
- Ask
- 0.20
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 771.2M
- Sector
- Healthcare
Prices in GBX except for Market Cap in GBP
About Apollon Formularies plc
Apollon Formularies Plc is a medical cannabis company based in the Commonwealth of Jamaica. It holds a suite of licences that allow for fully regulated seed through to human trial & drug discovery designed for patient treatment applications. Apollon Jamaica (Apollon UK’s subsidiary) is Cannabis Licensing Authority approved to produce large scale full spectrum cannabis oils that it can sell to patients via its regulated dispensary located at its state-of-the-art large scale processing laboratory, Negril, Jamaica. Apollon Jamaica is fitted to produce high volume, high quality, full spectrum medical cannabis oil with both high and low THC content and holds a Research & Development full spectrum license (inclusive of THC). This allows the company to undertake physician-led, medically supervised treatments for the purposes of drug discovery, all overseen and approved by the Jamaican Ministry of Health. The company’s aim is to ensure that Apollon is the recognised global brand for quality, consistency and efficacy.
Latest Trades
Date | Volume | Price (GBX) | Value (GBP) |
---|---|---|---|
02 Jun 23 11:48 | 500,000 | 0.14 | 700.00 |
30 May 23 15:40 | 21,512,554 | 0.18 | 38,722.60 |
30 May 23 15:40 | 6,233,866 | 0.17 | 10,597.57 |
30 May 23 15:39 | 15,278,688 | 0.17 | 25,973.77 |
25 May 23 11:20 | 500,000 | 0.17 | 850.00 |
Latest Announcements
Date | Title |
---|---|
10 May 23 17:05 | Apollon Formularies Plc - Update on Global Hemp Group |
11 Apr 23 14:00 | Apollon Formularies Plc - Result of General Meeting |
21 Mar 23 12:00 | Apollon Formularies Plc - 28 day due diligence extension for Asset sale |
15 Mar 23 07:00 | Apollon Formularies - Notice of General Meeting |
12 Jan 23 07:00 | Apollon Formularies - Execution of Binding Letter of Intent with GHG |
Address
Registered Address
42 One Love Drive, West End, Negril, Westmoreland, Jamaicabarnhillmd@sprynet.com
Phone
+44 (0)20 7440 0640
Contacts
Corporate Adviser
Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, EC2V 6EE, United KingdomRegistrar
Share Registrars Ltd, 3 The Millennium Centre, Crosby Way, Farnham, Surrey, GU9 7XX, United Kingdom